Telix Ebitda from 2010 to 2024

Stocks . Australia . 
Stock . Telix Pharmaceuticals
TLX Stock   23.60  0.84  3.69%   
Telix Pharmaceuticals EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA is likely to outpace its year average in 2024. From the period from 2010 to 2024, Telix Pharmaceuticals EBITDA quarterly data regression had mean square error of 1043 T and mean deviation of  25,747,766. View All Fundamentals
 
EBITDA  
First Reported
1998-12-31
Previous Quarter
23.7 M
Current Value
15.7 M
Quarterly Volatility
19.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 13.8 M, Other Operating Expenses of 521.5 M or Operating Income of 17.9 M, as well as many indicators such as . Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Telix Pharmaceuticals Technical models . Check out the analysis of Telix Pharmaceuticals Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY